Free Trial

Embecta (EMBC) Stock Price, News & Analysis

Embecta logo
$10.60 +0.17 (+1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$10.43 -0.17 (-1.60%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Embecta Stock (NASDAQ:EMBC)

Key Stats

Today's Range
$10.25
$10.65
50-Day Range
$9.28
$13.30
52-Week Range
$9.20
$21.48
Volume
365,040 shs
Average Volume
499,988 shs
Market Capitalization
$619.46 million
P/E Ratio
11.78
Dividend Yield
5.66%
Price Target
$19.33
Consensus Rating
Hold

Company Overview

Embecta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

EMBC MarketRank™: 

Embecta scored higher than 84% of companies evaluated by MarketBeat, and ranked 159th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Embecta has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Embecta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Embecta's stock forecast and price target.
  • Earnings Growth

    Earnings for Embecta are expected to grow by 7.72% in the coming year, from $2.85 to $3.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Embecta is 11.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Embecta is 11.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.58.

  • Price to Earnings Growth Ratio

    Embecta has a PEG Ratio of 0.64. PEG Ratios below 1 indicate that a company could be undervalued.

  • Read more about Embecta's valuation and earnings.
  • Percentage of Shares Shorted

    8.13% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 7.1.
  • Change versus previous month

    Short interest in Embecta has recently increased by 61.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Embecta is a leading dividend payer. It pays a dividend yield of 5.98%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Embecta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Embecta is 66.67%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Embecta will have a dividend payout ratio of 19.54% next year. This indicates that Embecta will be able to sustain or increase its dividend.

  • Read more about Embecta's dividend.
  • Percentage of Shares Shorted

    8.13% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 7.1.
  • Change versus previous month

    Short interest in Embecta has recently increased by 61.90%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Embecta this week, compared to 4 articles on an average week.
  • Search Interest

    2 people have searched for EMBC on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Embecta insiders have bought more of their company's stock than they have sold. Specifically, they have bought $106,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.42% of the stock of Embecta is held by insiders.

  • Percentage Held by Institutions

    93.83% of the stock of Embecta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Embecta's insider trading history.
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

EMBC Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
embecta to Participate in Investor Events
See More Headlines

EMBC Stock Analysis - Frequently Asked Questions

Embecta's stock was trading at $20.65 at the start of the year. Since then, EMBC stock has decreased by 48.6% and is now trading at $10.61.

Embecta Corp. (NASDAQ:EMBC) announced its quarterly earnings data on Friday, May, 9th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. Embecta's revenue for the quarter was down 9.8% on a year-over-year basis.
Read the conference call transcript
.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Embecta investors own include Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/09/2025
Record date for 6/13 Dividend
5/28/2025
Ex-Dividend for 6/13 Dividend
5/28/2025
Dividend Payable
6/13/2025
Today
7/09/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:EMBC
CIK
1872789
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$13.00
Potential Upside/Downside
+87.6%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
11.46
Forward P/E Ratio
3.62
P/E Growth
0.64
Net Income
$78.30 million
Pretax Margin
5.10%

Debt

Sales & Book Value

Annual Sales
$1.12 billion
Cash Flow
$3.42 per share
Price / Cash Flow
3.01
Book Value
($12.80) per share
Price / Book
-0.81

Miscellaneous

Free Float
58,198,000
Market Cap
$602.22 million
Optionable
Optionable
Beta
1.08
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:EMBC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners